Elusive Target of Angiogenesis in Small-Cell Lung Cancer

被引：5

作者：

Neal, Joel W. ^{[1
]}

Wakelee, Heather A. ^{[1
]}

机构：

[1] Stanford Univ, Sch Med, Stanford, CA 94305 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 12期

关键词：

RANDOMIZED PHASE-II; DOUBLE-BLIND; BEVACIZUMAB; CHEMOTHERAPY; PLACEBO; COMBINATION; CISPLATIN; THERAPY; MULTICENTER; CARBOPLATIN;

D O I：

10.1200/JCO.2016.71.6084

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：1269 / +

页数：4

共 24 条

[1] Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial [J].

Antonia, Scott J. ;

Lopez-Martin, Jose A. ;

Bendell, Johanna ;

Ott, Patrick A. ;

Taylor, Matthew ;

Eder, Joseph Paul ;

Jaeger, Dirk ;

Pietanza, M. Catherine ;

Le, Dung T. ;

de Braud, Filippo ;

Morse, Michael A. ;

Ascierto, Paolo A. ;

Horn, Leora ;

Amin, Asim ;

Pillai, Rathi N. ;

Evans, Jeffry ;

Chau, Ian ;

Bono, Petri ;

Atmaca, Akin ;

Sharma, Padmanee ;

Harbison, Christopher T. ;

Lin, Chen-Sheng ;

Christensen, Olaf ;

Calvo, Emiliano .

LANCET ONCOLOGY, 2016, 17 (07) :883-895

[2]

Arnold AM, 2007, J CLIN ONCOL, V25, P4278, DOI 10.1200/JCO.2007.12.3083

[3] Small Cell Lung Cancer: Can Recent Advances in Biology and Molecular Biology Be Translated into Improved Outcomes? [J].

Bunn, Paul A., Jr. ;

Minna, John D. ;

Augustyn, Alexander ;

Gazdar, Adi F. ;

Ouadah, Youcef ;

Krasnow, Mark A. ;

Berns, Anton ;

Brambilla, Elisabeth ;

Rekhtman, Natasha ;

Massion, Pierre P. ;

Niederst, Matthew ;

Peifer, Martin ;

Yokota, Jun ;

Govindan, Ramaswamy ;

Poirier, John T. ;

Byers, Lauren A. ;

Wynes, Murry W. ;

McFadden, David G. ;

MacPherson, David ;

Hann, Christine L. ;

Farago, Anna F. ;

Dive, Caroline ;

Teicher, Beverly A. ;

Peacock, Craig D. ;

Johnson, Jane E. ;

Cobb, Melanie H. ;

Wendel, Hans -Guido ;

Spigel, David ;

Sage, Julien ;

Yang, Ping ;

Pietanza, M. Catherine ;

Krug, Lee M. ;

Heymach, John ;

Ujhazy, Peter ;

Zhou, Caicun ;

Goto, Koichi ;

Dowlati, Afshin ;

Christensen, Camilla Laulund ;

Park, Keunchil ;

Einhorn, Lawrence H. ;

Edelman, Martin J. ;

Giaccone, Giuseppe ;

Gerber, David E. ;

Salgia, Ravi ;

Owonikoko, Taofeek ;

Malik, Shakun ;

Karachaliou, Niki ;

Gandara, David R. ;

Slotman, Ben J. ;

Blackhall, Fiona .

JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (04) :453-474

[4] A phase 1 study to evaluate the safety and tolerability of MEDI4736, an anti-PD-L1 antibody, in combination with tremelimumab in patients with advanced solid tumors [J].

Callahan, Margaret K. ;

Ott, Patrick Alexander ;

Odunsi, Kunle ;

Bertolini, Staphane V. ;

Pan, Linda S. ;

Venhaus, Ralph Rudolph ;

Karakunnel, Joyson Joseph ;

Hodi, F. Stephen ;

Wolchok, Jedd D. .

JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)

[5] Targeting VEGF in lung cancer [J].

Das, Millie ;

Wakelee, Heather .

EXPERT OPINION ON THERAPEUTIC TARGETS, 2012, 16 (04) :395-406

[6] Opinion - Angiogenesis: an organizing principle for drug discovery? [J].

Folkman, Judah .

NATURE REVIEWS DRUG DISCOVERY, 2007, 6 (04) :273-286

[7] Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial [J].

Garon, Edward B. ;

Ciuleanu, Tudor-Eliade ;

Arrieta, Oscar ;

Prabhash, Kumar ;

Syrigos, Konstantinos N. ;

Goksel, Tuncay ;

Park, Keunchil ;

Gorbunova, Vera ;

Dario Kowalyszyn, Ruben ;

Pikiel, Joanna ;

Czyzewicz, Grzegorz ;

Orlov, Sergey V. ;

Lewanski, Conrad R. ;

Thomas, Michael ;

Bidoli, Paolo ;

Dakhil, Shaker ;

Gans, Steven ;

Kim, Joo-Hang ;

Grigorescu, Alexandru ;

Karaseva, Nina ;

Reck, Martin ;

Cappuzzo, Federico ;

Alexandris, Ekaterine ;

Sashegyi, Andreas ;

Yurasov, Sergey ;

Perol, Maurice .

LANCET, 2014, 384 (9944) :665-673

[8] Bevacizumab Beyond First Progression Is Associated With Prolonged Overall Survival in Metastatic Colorectal Cancer: Results From a Large Observational Cohort Study (BRiTE) [J].

Grothey, Axel ;

Sugrue, Mary M. ;

Purdie, David M. ;

Dong, Wei ;

Sargent, Daniel ;

Hedrick, Eric ;

Kozloff, Mark .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (33) :5326-5334

[9] Phase II Study of Cisplatin Plus Etoposide and Bevacizumab for Previously Untreated, Extensive-Stage Small-Cell Lung Cancer: Eastern Cooperative Oncology Group Study E3501 [J].

Horn, Leora ;

Dahlberg, Suzanne E. ;

Sandler, Alan B. ;

Dowlati, Afshin ;

Moore, Dennis F. ;

Murren, John R. ;

Schiller, Joan H. .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (35) :6006-6011

[10] Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer [J].

Hurwitz, H ;

Fehrenbacher, L ;

Novotny, W ;

Cartwright, T ;

Hainsworth, J ;

Heim, W ;

Berlin, J ;

Baron, A ;

Griffing, S ;

Holmgren, E ;

Ferrara, N ;

Fyfe, G ;

Rogers, B ;

Ross, R ;

Kabbinavar, F .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (23) :2335-2342

← 1 2 3 →